Release Date: 02/03/18 08:21 Summary: Executive Director signs contract terms Price Sensitive: No Download Document 411.83KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%